Literature DB >> 12540293

Upstream stimulatory factor (USF) and neurogenic differentiation/beta-cell E box transactivator 2 (NeuroD/BETA2) contribute to islet-specific glucose-6-phosphatase catalytic-subunit-related protein (IGRP) gene expression.

Cyrus C Martin1, Christina A Svitek, James K Oeser, Eva Henderson, Roland Stein, Richard M O'Brien.   

Abstract

Islet-specific glucose-6-phosphatase (G6Pase) catalytic-subunit-related protein (IGRP) is a homologue of the catalytic subunit of G6Pase, the enzyme that catalyses the final step of the gluconeogenic pathway. The analysis of IGRP-chloramphenicol acetyltransferase (CAT) fusion-gene expression through transient transfection of islet-derived beta TC-3 cells revealed that multiple promoter regions, located between -306 and -97, are required for maximal IGRP-CAT fusion-gene expression. These regions correlated with trans -acting factor-binding sites in the IGRP promoter that were identified in beta TC-3 cells in situ using the ligation-mediated PCR (LMPCR) footprinting technique. However, the LMPCR data also revealed additional trans -acting factor-binding sites located between -97 and +1 that overlap two E-box motifs, even though this region by itself conferred minimal fusion-gene expression. The data presented here show that these E-box motifs are important for IGRP promoter activity, but that their action is only manifest in the presence of distal promoter elements. Thus mutation of either E-box motif in the context of the -306 to +3 IGRP promoter region reduces fusion-gene expression. These two E-box motifs have distinct sequences and preferentially bind NeuroD/BETA2 (neurogenic differentiation/beta-cell E box transactivator 2) and upstream stimulatory factor (USF) in vitro, consistent with the binding of both factors to the IGRP promoter in situ, as determined using the chromatin-immunoprecipitation (ChIP) assay. Based on experiments using mutated IGRP promoter constructs, we propose a model to explain how the ubiquitously expressed USF could contribute to islet-specific IGRP gene expression.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12540293      PMCID: PMC1223330          DOI: 10.1042/BJ20021585

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  48 in total

Review 1.  Pancreatic islet development.

Authors:  D E Bramblett; H P Huang; M J Tsai
Journal:  Adv Pharmacol       Date:  2000

Review 2.  Regulation of muscle regulatory factors by DNA-binding, interacting proteins, and post-transcriptional modifications.

Authors:  P L Puri; V Sartorelli
Journal:  J Cell Physiol       Date:  2000-11       Impact factor: 6.384

3.  Identification of a pancreatic beta-cell insulin gene transcription factor that binds to and appears to activate cell-type-specific expression: its possible relationship to other cellular factors that bind to a common insulin gene sequence.

Authors:  J Whelan; S R Cordle; E Henderson; P A Weil; R Stein
Journal:  Mol Cell Biol       Date:  1990-04       Impact factor: 4.272

4.  A mutational analysis of the insulin gene transcription control region: expression in beta cells is dependent on two related sequences within the enhancer.

Authors:  O Karlsson; T Edlund; J B Moss; W J Rutter; M D Walker
Journal:  Proc Natl Acad Sci U S A       Date:  1987-12       Impact factor: 11.205

5.  Homologous DNA sequences and cellular factors are implicated in the control of glucagon and insulin gene expression.

Authors:  M Cordier-Bussat; C Morel; J Philippe
Journal:  Mol Cell Biol       Date:  1995-07       Impact factor: 4.272

6.  Multiple promoter elements are required for the stimulatory effect of insulin on human collagenase-1 gene transcription. Selective effects on activator protein-1 expression may explain the quantitative difference in insulin and phorbol ester action.

Authors:  S C Chapman; J E Ayala; R S Streeper; A A Culbert; E M Eaton; C A Svitek; J K Goldman; J M Tavar; R M O'Brien
Journal:  J Biol Chem       Date:  1999-06-25       Impact factor: 5.157

7.  Molecular and biochemical analysis of the MODY syndromes.

Authors:  W E Winter
Journal:  Pediatr Diabetes       Date:  2000-06       Impact factor: 4.866

8.  Hepatic nuclear factor 3- and hormone-regulated expression of the phosphoenolpyruvate carboxykinase and insulin-like growth factor-binding protein 1 genes.

Authors:  R M O'Brien; E L Noisin; A Suwanichkul; T Yamasaki; P C Lucas; J C Wang; D R Powell; D K Granner
Journal:  Mol Cell Biol       Date:  1995-03       Impact factor: 4.272

9.  beta-cell-specific inactivation of the mouse Ipf1/Pdx1 gene results in loss of the beta-cell phenotype and maturity onset diabetes.

Authors:  U Ahlgren; J Jonsson; L Jonsson; K Simu; H Edlund
Journal:  Genes Dev       Date:  1998-06-15       Impact factor: 11.361

10.  PDX-1 is required for pancreatic outgrowth and differentiation of the rostral duodenum.

Authors:  M F Offield; T L Jetton; P A Labosky; M Ray; R W Stein; M A Magnuson; B L Hogan; C V Wright
Journal:  Development       Date:  1996-03       Impact factor: 6.868

View more
  11 in total

1.  Upstream stimulatory factor 1 associated with familial combined hyperlipidemia, LDL cholesterol, and triglycerides.

Authors:  Hilary Coon; Yuanpei Xin; Paul N Hopkins; Richard M Cawthon; Sandra J Hasstedt; Steven C Hunt
Journal:  Hum Genet       Date:  2005-06-16       Impact factor: 4.132

2.  Transcriptional regulation of the distal promoter of the rat pyruvate carboxylase gene by hepatocyte nuclear factor 3beta/Foxa2 and upstream stimulatory factors in insulinoma cells.

Authors:  Thirajit Boonsaen; Pinnara Rojvirat; Kathy H Surinya; John C Wallace; Sarawut Jitrapakdee
Journal:  Biochem J       Date:  2007-07-15       Impact factor: 3.857

Review 3.  Genetic Dissection and Clinical Features of MODY6 (NEUROD1-MODY).

Authors:  Yukio Horikawa; Mayumi Enya
Journal:  Curr Diab Rep       Date:  2019-02-22       Impact factor: 4.810

4.  NeuroD1 promotes tumor cell proliferation and tumorigenesis by directly activating the pentose phosphate pathway in colorectal carcinoma.

Authors:  Zhuolin Li; Yuxin He; Yanjun Li; Juan Li; Hezhao Zhao; Guanbing Song; Makoto Miyagishi; Shourong Wu; Vivi Kasim
Journal:  Oncogene       Date:  2021-10-16       Impact factor: 9.867

Review 5.  Glucose-6-phosphatase catalytic subunit gene family.

Authors:  John C Hutton; Richard M O'Brien
Journal:  J Biol Chem       Date:  2009-08-20       Impact factor: 5.157

6.  G6PC2 Modulates the Effects of Dexamethasone on Fasting Blood Glucose and Glucose Tolerance.

Authors:  Kayla A Boortz; Kristen E Syring; Rebecca A Lee; Chunhua Dai; James K Oeser; Owen P McGuinness; Jen-Chywan Wang; Richard M O'Brien
Journal:  Endocrinology       Date:  2016-09-21       Impact factor: 4.736

7.  Foxa2 and MafA regulate islet-specific glucose-6-phosphatase catalytic subunit-related protein gene expression.

Authors:  Cyrus C Martin; Brian P Flemming; Yingda Wang; James K Oeser; Richard M O'Brien
Journal:  J Mol Endocrinol       Date:  2008-08-27       Impact factor: 5.098

8.  Deregulation of CREB signaling pathway induced by chronic hyperglycemia downregulates NeuroD transcription.

Authors:  In-Su Cho; Miyoung Jung; Ki-Sun Kwon; Eunpyo Moon; Jang-Hyeon Cho; Kun-Ho Yoon; Ji-Won Kim; Young-Don Lee; Sung-Soo Kim; Haeyoung Suh-Kim
Journal:  PLoS One       Date:  2012-04-03       Impact factor: 3.240

9.  Intronic cis-regulatory modules mediate tissue-specific and microbial control of angptl4/fiaf transcription.

Authors:  J Gray Camp; Amelia L Jazwa; Chad M Trent; John F Rawls
Journal:  PLoS Genet       Date:  2012-03-29       Impact factor: 5.917

10.  Multiple E-boxes in the distal promoter of the rat pyruvate carboxylase gene function as a glucose-responsive element.

Authors:  Apilak Wutthisathapornchai; Tuangtong Vongpipatana; Sureeporn Muangsawat; Thirajit Boonsaen; Michael J MacDonald; Sarawut Jitrapakdee
Journal:  PLoS One       Date:  2014-07-23       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.